BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 11993504)

  • 21. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
    Dale SB; Verdier JM
    Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
    [No Abstract]   [Full Text] [Related]  

  • 22. Lessons for Medicare Part D in the hemodialysis community.
    Nayeem AI; Chertow GM
    BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
    [No Abstract]   [Full Text] [Related]  

  • 25. Health insurance oversight issue brief: mandated benefits: off-label drug coverage requirements: year end report--2004.
    Plaza CI
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-9. PubMed ID: 15726733
    [No Abstract]   [Full Text] [Related]  

  • 26. Incentives in the Medicare prescription drug benefit.
    Natl Bur Econ Res Bull Aging Health; 2006; (15):1-2. PubMed ID: 16805056
    [No Abstract]   [Full Text] [Related]  

  • 27. The Medicare drug card.
    Stoker J
    Home Healthc Nurse; 2005 Jun; 23(6):364-5. PubMed ID: 15956854
    [No Abstract]   [Full Text] [Related]  

  • 28. The last prescription drug benefit: the Medicare Catastrophic Coverage Act of 1988.
    Pentecost MJ
    J Am Coll Radiol; 2006 Apr; 3(4):240-2. PubMed ID: 17412053
    [No Abstract]   [Full Text] [Related]  

  • 29. Medicare and prescription drugs.
    Iglehart JK
    N Engl J Med; 2001 Mar; 344(13):1010-5. PubMed ID: 11274630
    [No Abstract]   [Full Text] [Related]  

  • 30. Finance issue brief: mandated benefits: off-label drug coverage requirements: year end report-2003.
    Plaza CI
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-9. PubMed ID: 14870745
    [No Abstract]   [Full Text] [Related]  

  • 31. The first months of the prescription-drug benefit--a CMS update.
    Bach PB; McClellan MB
    N Engl J Med; 2006 Jun; 354(22):2312-4. PubMed ID: 16738266
    [No Abstract]   [Full Text] [Related]  

  • 32. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using clinical evidence to manage pharmacy benefits: experiences of six states.
    Bergman D; Hoadley J; Kaye N; Crowley J; Hostetter M
    Issue Brief (Commonw Fund); 2006 Mar; (899):1-14. PubMed ID: 16562357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Medicare hospice benefit.
    National Hospice and Palliative Care Organization (NHPCO).
    Issue Brief Cent Medicare Educ; 2001; 2(9):1-6. PubMed ID: 11859903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacy benefits for Medicare: a "triple-edged" sword.
    Penna P
    Manag Care Interface; 2001 Oct; 14(10):57-8. PubMed ID: 11688094
    [No Abstract]   [Full Text] [Related]  

  • 36. Finance issue brief: mandated benefits: osteoporosis coverage requirements: year end report-2003.
    Plaza CI
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-4. PubMed ID: 14870744
    [No Abstract]   [Full Text] [Related]  

  • 37. Medicare program; changes to the Medicare Advantage and the Medicare prescription drug benefit programs for contract year 2013 and other changes. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2012 Apr; 77(71):22072-175. PubMed ID: 22606715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lessons from Medicare+Choice for Medicare reform.
    Dallek G; Biles B; Hersch Nicholas L
    Policy Brief Commonw Fund; 2003 Jun; (658):1-17. PubMed ID: 12833910
    [No Abstract]   [Full Text] [Related]  

  • 39. Dual eligibles.
    Nemore P
    Issue Brief Cent Medicare Educ; 2004; 5(2):1-6. PubMed ID: 15053007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.